Kory James Wentworth

Insider Reports History

Entity
Individual
Location
6 Tide Street, C/O Entrada Therapeutics, Boston, MA
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kory James Wentworth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Chief Financial Officer Common Stock 73.8K $1.48M $20.00 Dec 2, 2024 Direct
Entrada Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 31.2K Dec 2, 2024 Direct

Insider Reports Filed by Kory James Wentworth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRDA Entrada Therapeutics, Inc. Nov 29, 2024 6 -$107K 4 Dec 3, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Nov 11, 2024 3 -$160K 4 Nov 13, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Sep 9, 2024 1 -$47.8K 4 Sep 10, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Sep 3, 2024 5 -$27.1K 4 Sep 5, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Jul 8, 2024 1 -$26.3K 4 Jul 10, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Mar 15, 2024 2 $18.9K 4 Mar 19, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Mar 6, 2024 1 -$50.3K 4 Mar 8, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2024 5 -$27.7K 4 Mar 5, 2024 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Dec 21, 2023 10 -$169K 4 Dec 26, 2023 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Sep 1, 2023 5 -$19K 4 Sep 6, 2023 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Jul 10, 2023 6 -$159K 4 Jul 12, 2023 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Jun 29, 2023 2 $18.5K 4 Jun 30, 2023 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Jun 21, 2023 4 -$226K 4 Jun 23, 2023 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2023 2 $0 4/A Apr 19, 2023 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Dec 8, 2022 3 -$76.7K 4 Dec 12, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Dec 2, 2022 6 -$50K 4 Dec 6, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Nov 16, 2022 3 -$3.2K 4 Nov 18, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Sep 1, 2022 1 $0 4 Sep 6, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Aug 24, 2022 5 -$62K 4 Aug 26, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Aug 19, 2022 9 -$140K 4 Aug 23, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Aug 16, 2022 9 -$7.18K 4 Aug 18, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 1 $0 4 Nov 1, 2021 Chief Financial Officer
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Chief Financial Officer